Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study-Reference-Cited by-同舟云学术

Post-transplant cyclophosphamide pharmacokinetics and haploidentical hematopoietic cell transplantation outcomes: an exploratory study

Published:2022-06-14 Issue:11 Volume:63 Page:2679-2685
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Kasudhan Kripa Shanker¹,Patil Amol N.¹^ORCID,Jandial Aditya²,Khadwal Alka²,Prakash Gaurav²,Jain Arihant²,Bhurani Dinesh³^ORCID,Ahmed Rayaz³,Agrawal Narendra³,Singh Reema³,Sachdeva Man Updesh Singh⁴,Varma Neelam⁴,Das Reena⁴^ORCID,Verma Attri Savita⁵,Malhotra Samir¹,Majhail Navneet S.⁶,Malhotra Pankaj²,Lad Deepesh P.²^ORCID

Affiliation:

1. Department of Clinical Pharmacology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

2. Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

3. Department of Hemato-Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India

4. Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India

5. Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India

6. Blood and Marrow Transplant Program, Department of Hematology-Oncology, Cleveland Clinic, Cleveland, OH, USA

Funder

Indian Council of Medical Research

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2087067

Reference27 articles.

1. Erratum: Modern approaches to HLA-haploidentical blood or marrow transplantation.

2. Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression

3. Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide

4. Metabolism-based cyclophosphamide dosing for hematopoietic cell transplant

5. Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients*

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Leukocyte Antigen–Haploidentical Haematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide for Paediatric Haematological Malignancies;Cancers;2024-01-31

2. Pharmacokinetic assessment of rifampicin and des-acetyl rifampicin in carbon tetrachloride induced liver injury model in Wistar rats;Journal of Complementary and Integrative Medicine;2023-12-25

3. Pharmacokinetic Assessment of Pyrazinamide and Pyrazinoic Acid in Carbon tetrachloride-induced Liver Injury Model in Wistar Rats;Journal of Pharmacy and Bioallied Sciences;2023